These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 10070977)
1. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Markwalder R; Reubi JC Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977 [TBL] [Abstract][Full Text] [Related]
2. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125 [TBL] [Abstract][Full Text] [Related]
3. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications. Fleischmann A; Waser B; Reubi JC Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282 [TBL] [Abstract][Full Text] [Related]
4. Early over-expression of GRP receptors in prostatic carcinogenesis. Körner M; Waser B; Rehmann R; Reubi JC Prostate; 2014 Feb; 74(2):217-24. PubMed ID: 24150752 [TBL] [Abstract][Full Text] [Related]
5. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts. de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703 [TBL] [Abstract][Full Text] [Related]
6. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Halmos G; Wittliff JL; Schally AV Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958 [TBL] [Abstract][Full Text] [Related]
7. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting. Reubi C; Gugger M; Waser B Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125 [TBL] [Abstract][Full Text] [Related]
8. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515 [TBL] [Abstract][Full Text] [Related]
9. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. Lantry LE; Cappelletti E; Maddalena ME; Fox JS; Feng W; Chen J; Thomas R; Eaton SM; Bogdan NJ; Arunachalam T; Reubi JC; Raju N; Metcalfe EC; Lattuada L; Linder KE; Swenson RE; Tweedle MF; Nunn AD J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Pinski J; Reile H; Halmos G; Groot K; Schally AV Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203 [TBL] [Abstract][Full Text] [Related]
11. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Gugger M; Reubi JC Am J Pathol; 1999 Dec; 155(6):2067-76. PubMed ID: 10595936 [TBL] [Abstract][Full Text] [Related]
12. High affinity binding sites for gastrin releasing peptide on human gastric cancer and Ménétrier's mucosa. Preston SR; Woodhouse LF; Jones-Blackett S; Wyatt JI; Primrose JN Cancer Res; 1993 Nov; 53(21):5090-2. PubMed ID: 8221641 [TBL] [Abstract][Full Text] [Related]
13. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies. Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195 [TBL] [Abstract][Full Text] [Related]
14. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933 [TBL] [Abstract][Full Text] [Related]
15. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417 [TBL] [Abstract][Full Text] [Related]
16. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature. Reubi JC; Fleischmann A; Waser B; Rehmann R Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611 [TBL] [Abstract][Full Text] [Related]
17. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. Reile H; Armatis PE; Schally AV Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709 [TBL] [Abstract][Full Text] [Related]
18. Bombesin receptors in a human duodenal tumor cell line: binding properties and function. Williams BY; Schonbrunn A Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice. Stangelberger A; Schally AV; Varga JL; Zarandi M; Szepeshazi K; Armatis P; Halmos G Clin Cancer Res; 2005 Jan; 11(1):49-57. PubMed ID: 15671527 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]